yersinia
pesti
outer
protein
plasminogen
activ
proteas
yop
secret
protein
f
necessari
full
virul
yesinia
pesti
propos
potenti
protect
antigen
vaccin
plagu
current
studi
use
dna
immun
tool
studi
rel
protect
immun
protein
standard
intranas
challeng
system
mice
natur
full
length
gene
sequenc
pesti
protein
display
good
level
protein
express
vitro
deliv
dna
vaccin
vector
overal
immunogen
wild
type
gene
dna
vaccin
low
elicit
antigenspecif
antibodi
respons
gene
sequenc
modif
improv
paramet
howev
even
modifi
yopd
yopo
yscf
antigen
abl
partial
protect
immun
mice
variou
level
lethal
challeng
pesti
kim
strain
protect
observ
either
yopb
pla
antigen
result
demonstr
dna
immun
effect
screen
optim
compar
optim
antigen
design
immunogen
candid
antigen
develop
subunitbas
plagu
vaccin
plagu
one
fear
infecti
diseas
human
kill
million
human
throughout
histori
still
remain
endem
certain
area
world
caus
agent
plagu
yersinia
pesti
pesti
also
concern
potenti
use
agent
biolog
warfar
biolog
terror
although
kill
wholecel
vaccin
avail
human
use
certain
countri
poor
efficaci
limit
use
prevent
natur
humaninflict
outbreak
point
effort
develop
next
gener
plagu
vaccin
focus
mainli
use
two
wellstudi
protect
antigen
v
lcrv
form
subunitbas
recombin
protein
vaccin
howev
shown
recent
studi
conduct
human
subunitbas
plagu
vaccin
immunogen
current
vaccin
composit
quit
weak
therefor
import
identifi
addit
protect
antigen
clear
especi
highli
virul
pneumon
plagu
previou
studi
shown
antibodi
yersinia
outer
protein
yop
present
convalesc
sera
patient
infect
pesti
mice
surviv
experiment
challeng
therefor
hypothes
protein
may
serv
protect
antigen
along
lcrv
yop
plasminogen
activ
proteas
pla
necessari
full
virul
pesti
encod
virul
plasmid
among
secret
yop
yopb
yopd
known
transloc
yscyop
type
iii
secret
system
involv
transloc
yop
effector
across
eukaryot
cell
plasma
membran
target
cell
type
iii
secret
apparatu
pesti
conserv
mechan
deliv
virul
factor
mammalian
host
cell
yopb
yopd
transmembran
protein
interact
lcrv
form
pore
type
iii
secret
apparatu
yop
effector
transloc
yopoypka
kda
protein
kinas
abil
catalyz
autophosphoryl
serin
residu
shown
vitro
experi
target
inner
surfac
plasma
membran
insid
cell
recent
report
demonstr
mice
immun
recombin
yscf
surfac
local
protein
produc
yscfspecif
antibodi
respons
partial
protect
immun
pesti
intraven
subcutan
challeng
particular
result
suggest
antibodi
respons
induc
yscf
protein
immun
use
protect
bubon
plagu
although
protect
mechan
quit
clear
evid
whether
yscfspecif
antibodi
respons
protect
mucos
infect
includ
pneumon
plagu
pla
integr
outer
membran
protein
surfac
proteas
belong
omptin
famili
enterobacteri
surfac
protein
deriv
name
fact
activ
mammalian
plasma
proenzym
plasminogen
plasmin
import
pla
bacteri
virul
demonstr
vivo
planeg
mutant
strain
close
bacteria
compar
less
bacteria
isogen
plaposit
strain
protein
respons
highli
effici
invas
plagu
bacterium
subcutan
infect
site
circul
furthermor
recent
data
shown
intranas
infect
pesti
strain
lack
pla
result
develop
deadli
plagu
infect
day
infect
mice
compar
fatal
rate
less
day
postinocul
wild
type
strain
indic
pla
signific
involv
fatal
outcom
follow
respiratori
infect
pesti
immunogen
potenti
protect
well
character
yop
pla
protein
one
studi
use
recombin
yop
protein
express
escherichia
coli
e
coli
purifi
histag
approach
recombin
yopo
protein
significantli
prolong
mean
surviv
time
increas
overal
surviv
mice
receiv
subcutan
challeng
virul
nonencapsul
isogen
variant
pesti
studi
yopd
also
shown
partial
protect
death
mice
challeng
nonencapsul
strain
wildtyp
encapsul
pesti
detail
data
provid
regard
antibodi
respons
individu
yop
protein
author
also
note
sever
yop
protein
denatur
use
immunogen
may
contribut
poor
protect
yop
protein
recent
year
dna
vaccin
approach
use
effect
tool
studi
immunogen
candid
antigen
varieti
infecti
agent
due
potenti
express
protect
antigen
vivo
exampl
dna
immun
use
quickli
confirm
spike
protein
protect
antigen
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
map
protect
domain
spike
protein
dna
immun
also
use
effect
identifi
individu
protect
antigen
order
formul
subunitbas
vaccin
smallpox
infect
previou
studi
laboratori
success
establish
mous
intranas
challeng
model
coupl
dna
immun
technolog
test
protect
efficaci
modifi
pesti
antigen
lethal
plagu
challeng
system
provid
standard
assay
process
screen
score
rel
effect
known
novel
pesti
antigen
current
studi
molecular
antigen
engin
approach
use
improv
express
immunogen
yop
yscf
pla
protein
previou
studi
use
dna
vaccin
plagu
infecti
agent
demonstr
proper
leader
sequenc
import
elicit
high
level
antibodi
respons
protect
immun
sinc
yopb
yopd
yopo
gene
encod
typic
signal
peptid
tpa
leader
sequenc
engin
yop
gene
individu
produc
modifi
yop
gene
insert
dna
immun
addit
certain
intragen
hydrophob
region
remov
improv
immunogen
yop
antigen
result
demonstr
antigen
engin
effect
improv
immunogen
yop
pla
yscf
antigen
modifi
antigen
gener
induc
higher
antibodi
respons
wildtyp
gene
insert
addit
modifi
yopd
yopo
yscf
protein
improv
level
protect
overal
protect
efficaci
pesti
protein
still
low
incomplet
compar
known
protect
antigen
lcrv
indic
search
addit
protect
antigen
pesti
need
pesti
strain
kim
fulli
virul
contain
known
virul
factor
prepar
grow
inocula
h
tryptos
blood
agar
base
difco
supplement
mm
cacl
without
addit
blood
bacteria
remov
plate
inocul
loop
resuspend
injectiongrad
pb
bacteria
count
suspens
correl
optic
densiti
od
number
bacteria
final
inocula
confirm
coloni
count
pesti
gene
yopb
yopd
yopo
pla
yscf
first
amplifi
pfu
polymeras
strategen
ca
plasmid
yopb
yopd
yopoypka
encod
kb
plasmid
pla
encod
kb
plasmid
primer
pair
shown
tabl
two
dna
vaccin
construct
primer
pair
made
express
either
yopb
yopd
yopo
three
construct
pla
yopb
construct
full
length
yopb
wtyopb
gene
amplifi
primer
truncat
yopb
yopbdtm
gene
follow
remov
hydrophob
region
first
amplifi
two
gene
fragment
yopb
gene
yopb
gene
fragment
primer
pair
respect
two
fragment
ligat
togeth
induc
hindiii
site
junction
yopd
dna
vaccin
construct
full
length
yopd
wtyopd
gene
amplifi
primer
truncat
yopd
yopddtm
gene
follow
remov
hydrophob
region
first
amplifi
two
gene
fragment
yopd
gene
yopd
gene
fragment
primer
pair
respect
two
fragment
ligat
togeth
induc
psti
site
junction
hydrophob
region
nterminu
pla
protein
repres
natur
signal
peptid
sever
version
pla
dna
vaccin
construct
without
remov
ntermin
hydrophob
region
full
length
pla
gene
dpla
gene
follow
remov
hydrophob
region
nterminu
pla
amplifi
primer
pair
respect
gene
insert
directli
subclon
previous
describ
dna
vaccin
vector
immedi
downstream
tpa
leader
sequenc
infram
subclon
insert
full
length
yopo
gene
amplifi
primer
clone
without
tpa
leader
sequenc
produc
wtyopo
tpayopo
dna
vaccin
respect
three
yscf
dna
vaccin
construct
singl
copi
yscf
gene
without
tpa
leader
sequenc
two
copi
yscf
gene
tandem
wild
type
full
length
yscf
gene
amplifi
primer
fragment
twocopi
yscf
tandem
gene
insert
amplifi
primer
pair
respect
two
fragment
ligat
togeth
induc
spei
site
linker
alaalathrserthrserhisvalasp
junction
wild
type
yscf
twocopi
yscf
tandem
insert
subclon
vector
hindiii
bamhi
site
without
use
leader
sequenc
tpayscf
insert
amplifi
primer
subclon
vector
immedi
downstream
tpa
leader
sequenc
suffici
amount
dna
vaccin
prepar
qiagen
mega
plasmid
purif
kit
valencia
ca
vitro
transfect
anim
immun
applic
dna
vaccin
plagu
antigen
v
construct
previous
report
use
posit
control
intranas
challeng
studi
previous
shown
provid
protect
mucos
challeng
model
mice
six
eight
week
old
femal
balbc
mice
micegroup
purchas
tacon
farm
germantown
ny
hous
depart
anim
medicin
univers
massachusett
medic
school
umm
accord
iacuc
approv
protocol
anim
immun
helio
gene
gun
biorad
use
helium
ga
pressur
psi
accord
manufactur
instruct
mous
receiv
four
monthli
immun
six
dna
shot
immun
blood
sampl
collect
periorbit
prior
immun
week
last
immun
express
yopb
yopd
yopo
pla
yscf
dna
vaccin
test
transient
transfect
cell
calcium
phosphat
coprecipit
method
use
plasmid
dna
cell
dish
cell
harvest
hour
transfect
transient
express
yopb
yopd
yopo
pla
yscf
antigen
analyz
polyacryamid
gel
electrophoresi
sdspage
transfer
onto
pvdf
membran
block
overnight
block
buffer
iblock
pb
membran
incub
dilut
group
pool
mous
sera
immun
correspond
dna
vaccin
mous
sera
yopb
yopd
yopo
pla
yscf
gener
yopbdtm
yopddtm
tpayopo
tpadpla
dna
vaccin
respect
wash
blot
incub
alkalin
phosphataseconjug
goat
antimous
igg
dilut
signal
detect
use
chemiluminesc
westernlight
kit
tropix
bedford
enzymelink
immunosorb
assay
elisa
perform
measur
titer
specif
igg
individu
pesti
antigen
pool
mous
sera
group
equal
amount
serum
mous
group
first
pool
dilut
test
yopb
yopd
yopo
antigen
use
elisa
supernat
cell
transfect
yopbdtm
yopddtm
tpayopo
dna
vaccin
respect
nonpurifi
pla
yscf
antigen
use
elisa
cell
lysat
transfect
tpapla
dna
vaccin
respect
ninetysixwel
microtit
plate
coat
one
antigen
harvest
transfect
cell
incub
overnight
serial
dilut
mous
sera
ad
plate
assay
duplic
plate
incub
biotinyl
antimous
igg
dilut
follow
horseradish
peroxidaseconjug
streptavidin
dilut
final
develop
tmb
solut
reaction
stop
ad
h
plate
read
od
challeng
perform
intranas
instil
salin
contain
lethal
dose
pesti
kim
strain
ketamin
anesthet
mice
kim
fulli
virul
pesti
strain
contain
known
virul
factor
challeng
method
lead
rapid
infect
lethal
nonimmun
mice
within
day
ld
median
lethal
dose
challeng
model
determin
previou
studi
cfu
equal
approxim
ld
individu
mice
challeng
one
week
fourth
immun
observ
twice
daili
monitor
morbid
mortal
studi
conduct
biosafeti
level
contain
facil
depart
anim
medicin
umm
fisher
exact
test
use
compar
protect
efficaci
pesti
infect
differ
vaccin
group
pesti
antigen
yopb
yopd
two
version
dna
vaccin
insert
design
fig
respect
yop
protein
contain
least
one
hydrophob
region
potenti
transmembran
tm
segment
middl
polypeptid
sequenc
therefor
one
modifi
version
dna
insert
dtm
hydrophob
region
remov
wild
type
version
wtyopb
wtyopd
retain
full
length
sequenc
human
tissu
plasminogen
activ
leader
sequenc
tpa
includ
version
insert
facilit
express
dna
vaccin
antigen
mammalian
cell
previous
report
yopo
contain
signific
hydrophob
segment
tpa
leader
ad
full
length
gene
insert
control
yopo
gene
insert
produc
wild
type
sequenc
without
identifi
leader
sequenc
fig
yop
gene
insert
individu
clone
dna
vaccin
vector
driven
cytomegaloviru
cmv
promot
previou
report
use
effect
lcrv
dna
vaccin
mammalian
cell
express
yop
dna
vaccin
confirm
use
transient
transfect
cell
system
vitro
cell
lysat
cultur
supernat
collect
transfect
examin
western
blot
analysi
yopb
antigen
express
observ
full
length
yopb
modifi
yopb
gene
insert
fig
modifi
yopb
insert
remov
hydrophob
region
display
good
level
express
cell
lysat
supernat
therefor
remov
aa
middl
yopb
gene
greatli
enhanc
secret
yopb
protein
fig
hand
impact
remov
much
smaller
aa
hydrophob
sequenc
express
yopd
limit
full
length
yopd
modifi
yopd
dna
vaccin
abl
express
compar
level
antigen
cell
lysat
supernat
fig
role
leader
sequenc
express
yopo
protein
signific
compar
yopo
dna
vaccin
without
leader
sequenc
wtyopo
yopo
construct
tpa
leader
tpayopo
abl
produc
larger
amount
yopo
protein
supernat
support
util
tpa
leader
express
secret
protein
fig
interestingli
addit
tpa
leader
also
led
overal
higher
level
express
yopo
protein
even
though
exact
mechan
role
well
elucid
previou
data
demonstr
dna
immun
pla
gene
wild
type
sequenc
immunogen
despit
possibl
put
leader
sequenc
hydrophob
amino
acid
residu
nterminu
pla
although
addit
tpa
leader
wild
type
pla
sequenc
abl
achiev
better
express
pla
protein
transient
transfect
cell
still
immunogen
current
studi
anoth
modifi
pla
dna
vaccin
construct
remov
natur
hydrophob
sequenc
keep
tpa
leader
fig
transient
express
pla
confirm
new
dna
vaccin
plasmid
version
pla
dna
insert
abl
express
pla
antigen
cell
lysat
fig
three
version
dna
vaccin
insert
design
yscf
antigen
fig
yscf
small
protein
without
leader
sequenc
therefor
one
construct
full
length
wild
type
yscf
wtyscf
anoth
modifi
yscf
tpa
leader
sequenc
tpayscf
made
improv
express
immunogen
yscf
third
yscf
dna
vaccin
twocopi
tandem
yscf
antigen
design
construct
yscf
gene
insert
individu
clone
dna
vaccin
vector
transient
express
three
yscf
dna
vaccin
construct
cell
demonstr
wtyscf
tpayscf
induc
detect
yscf
antigen
express
fig
although
addit
tpa
leader
sequenc
could
improv
overal
express
mani
antigen
improv
yscf
express
current
tpayscf
dna
vaccin
design
interestingli
antigen
wellexpress
dimer
yscf
protein
expect
size
kda
fig
nonspecif
band
marker
across
transfect
sampl
includ
vector
control
seen
vector
control
sampl
fig
depend
cell
condit
observ
mous
sera
sometim
may
show
nonspecif
reactiv
cell
lysat
sampl
unpublish
observ
pesti
antigenspecif
antibodi
respons
measur
elisa
use
pool
mice
sera
immun
group
micegroup
two
week
third
monthli
dna
vaccin
yopbdtm
dna
vaccin
induc
posit
antiyopb
igg
respons
full
length
yopb
dna
vaccin
induc
detect
antibodi
respons
fig
antiyopd
igg
respons
elicit
full
length
modifi
ie
remov
hydrophob
domain
dna
vaccin
howev
latter
immunogen
indic
elicit
higher
antiyopd
igg
compar
full
length
yopd
insert
fig
therefor
delet
hydrophob
region
improv
immunogen
yopb
yopd
dna
vaccin
yopo
dna
vaccin
tpa
leader
tpayopo
also
abl
induc
higher
titer
antiyopd
antibodi
respons
wild
type
yopo
dna
vaccin
wtyopo
fig
base
reciproc
endtitr
titer
modifi
yopd
yopo
construct
abl
induc
higher
level
antibodi
respons
rang
modifi
yopb
dna
vaccin
tpadpla
dna
vaccin
remov
ntermin
hydrophob
region
clearli
abl
induc
posit
antipla
igg
respons
fig
even
though
final
titer
still
rel
low
low
immunogen
pla
dna
vaccin
complet
unexpect
given
none
modifi
pla
dna
vaccin
construct
abl
induc
signific
level
secret
pla
protein
supernat
fraction
transfect
cell
fig
signific
antipla
igg
antibodi
respons
detect
mice
immun
either
wtpla
tpapla
dna
vaccin
previous
report
interest
note
tpadpla
construct
immunogen
tpapla
construct
show
similar
pattern
pla
protein
express
inde
would
impli
ntermin
hydrophob
region
neg
effect
immunogen
pla
protein
deliv
via
dna
vaccin
vector
yscfspecif
antibodi
respons
produc
mice
receiv
dna
vaccin
fig
receiv
wtyscf
tpayscf
dna
vaccin
result
consist
find
dna
vaccin
detect
yscf
protein
express
fig
yscfspecif
igg
titer
three
monthli
dna
immun
immun
mice
current
studi
subclass
present
sera
analysi
ratio
less
data
shown
expect
base
well
establish
inform
literatur
gene
gun
mediat
dna
immun
mainli
induc
type
antibodi
respons
ratio
mice
micegroup
receiv
anoth
boost
dna
vaccin
week
one
week
later
challeng
lethal
dose
kim
strain
pesti
cfu
ld
deliv
intranas
three
dna
vaccin
modifi
pesti
gene
insert
yopddtm
tpayopo
abl
provid
partial
protect
measur
surviv
week
observ
fig
yopddtm
tpayopo
immun
group
mice
surviv
intranas
challeng
statist
differ
observ
fisher
exact
test
possibl
enough
statist
power
micegroup
compar
observ
differ
immun
group
mice
surviv
intranas
challeng
signific
compar
either
wtyscf
tpayscf
dna
vaccin
accord
fisher
exact
test
p
protect
observ
wtyopd
wtyscf
tpayscf
dna
vaccin
yopb
pla
dna
vaccin
fig
although
wtyopo
wtyopd
yopbdtm
dna
vaccin
induc
good
level
antibodi
respons
fig
mock
dna
immun
group
receiv
empti
dna
vector
without
pesti
antigen
insert
quickli
develop
easili
observ
sign
sick
eg
rough
coat
hunch
huddl
postur
shiver
labor
breath
lethargi
within
first
h
postchalleng
die
within
five
day
fig
mice
immun
yopb
pla
dna
vaccin
show
improv
mock
empti
vector
control
dna
immun
group
fig
posit
control
group
immun
combin
v
dna
vaccin
achiev
protect
fig
current
studi
compar
rel
immunogen
wild
type
modifi
antigen
three
yop
antigen
pla
antigen
yscf
antigen
demonstr
dna
vaccin
use
effect
tool
studi
rel
immunogen
candid
protect
antigen
optim
design
antigen
screen
new
antigen
pesti
overal
yopb
yopd
yopo
pla
yscf
dna
vaccin
immunogen
wild
type
gene
sequenc
deliv
dna
immun
product
antigen
mammalian
express
system
limit
lack
proper
leader
sequenc
andor
presenc
hydrophob
segment
middl
code
sequenc
antigen
engin
approach
use
tpa
leader
sequenc
remov
intrapolypeptid
hydrophob
region
effect
improv
express
code
yop
antigen
result
higher
level
antigen
express
secret
form
antigen
protein
gener
modifi
yop
dna
insert
led
better
immunogen
compar
wild
type
counterpart
yopb
kda
protein
two
put
hydrophob
domain
yopd
kda
protein
acid
hydrophob
region
middl
protein
remov
hydrophob
region
clearli
improv
immunogen
protein
although
modifi
yopd
insert
similar
level
antigen
express
full
length
yopd
insert
modifi
dna
vaccin
insert
also
becam
better
protect
antigen
yopd
yopo
protein
inform
immunogen
protect
potenti
yop
antigen
limit
literatur
studi
conduct
show
yopd
yopo
partial
protect
mostli
noncapsul
pesti
strain
subcutan
challeng
model
certain
case
effect
protect
shown
extend
length
surviv
improv
percentag
surviv
current
studi
attempt
link
antigen
express
immunogen
specif
antibodi
induct
final
protect
anim
immun
plagu
mucos
challeng
model
result
demonstr
antigen
engin
effect
improv
antigen
express
immunogen
final
protect
yop
protein
includ
studi
qualiti
protect
induc
modifi
yopd
yopo
antigen
better
previous
report
antigen
provid
better
surviv
wild
type
antigen
mucos
challeng
highli
virul
pesti
kim
strain
howev
current
design
still
suffici
elicit
full
protect
use
alon
knowledg
first
studi
show
antipla
antibodi
respons
could
induc
dna
immun
effect
achiev
remov
ntermin
hydrophob
region
make
strategi
differ
two
previou
design
pla
dna
vaccin
immunogen
result
suggest
ntermin
hydrophob
region
bacteri
protein
may
function
signal
peptid
leader
sequenc
mani
viral
protein
inform
import
design
bacteri
vaccin
use
genebas
ie
dna
viral
vector
vaccin
approach
human
applic
yscf
kda
surfac
local
protein
encod
plasmid
polymer
yscf
shown
form
needl
structur
refer
injectosom
type
iii
secret
system
least
six
yop
effector
yoph
yope
yopm
ypka
yopk
yopj
deliv
yscf
injectosom
target
eukaryot
cell
base
fact
yscf
surfaceexpress
protein
requir
virul
pesti
assum
yscf
might
candid
protect
antigen
recent
studi
show
immun
purifi
yscf
protein
could
induc
limit
protect
immun
experiment
plagu
infect
howev
convent
yscf
dna
vaccin
wild
type
gene
insert
even
addit
tpa
leader
sequenc
could
induc
detect
antibodi
respons
protect
immun
lethal
pesti
challeng
interestingli
dna
vaccin
construct
produc
yscf
dimer
protein
induc
yscfspecif
antibodi
respons
signific
level
protect
known
natur
polymer
yscf
protein
form
injectosom
type
iii
secret
system
dimer
design
dna
vaccin
might
produc
antibodi
respons
polymer
yscf
conform
may
critic
induct
protect
immun
yscfdna
vaccin
addit
overal
improv
yscf
protein
express
immunogen
current
studi
test
design
tpa
leader
dimer
compon
put
two
chang
togeth
hard
see
whether
may
interfer
futur
studi
includ
design
optim
immunogen
yscf
antigen
result
current
report
suggest
antigen
conform
critic
candid
protect
antigen
includ
pesti
result
also
provid
import
inform
aid
design
form
subunitbas
vaccin
includ
recombin
protein
vaccin
among
five
pesti
antigen
includ
current
analysi
three
antigen
yopd
yopo
yscf
abl
provid
partial
protect
induc
signific
level
antigenspecif
antibodi
respons
titer
optim
design
although
modifi
yopb
dna
vaccin
induc
high
level
antibodi
respons
protect
mice
intranas
pesti
challeng
furthermor
pla
dna
vaccin
induc
low
level
antibodi
respons
also
provid
protect
lethal
pesti
challeng
given
need
identifi
new
protect
antigen
improv
plagu
vaccin
antigen
optim
strategi
test
system
report
offer
effici
reproduc
platform
screen
new
protect
pesti
antigen
use
dna
immun
modifi
optim
immunogen
candid
pesti
antigen
use
acceler
effort
addit
optim
dna
vaccin
express
pesti
antigen
also
use
part
dna
primeprotein
boost
regimen
may
immunogen
protein
alon
approach
elicit
high
qualiti
protect
antibodi
respons
shown
hiv
vaccin
studi
schemat
diagram
yscf
gene
insert
dna
vaccin
construct
wtyscf
tpayscf
respect
repres
full
length
yscf
gene
alon
full
length
yscf
gene
addit
tpa
leader
sequenc
twocopi
yscf
gene
tandem
b
westernblot
analysi
yscf
protein
express
dna
vaccin
encod
wtyscf
tpayscf
protein
plu
empti
vector
supernat
lysat
l
transient
transfect
cell
pool
sera
mice
immun
dna
vaccin
use
dilut
detect
antibodi
arrow
point
dimer
form
yscf
antigenspecif
igg
respons
induc
differ
yopb
yopd
yopo
pla
yscf
dna
vaccin
balbc
mice
third
dna
immun
level
antibodi
respons
measur
elisa
autolog
antigen
express
cell
transfect
dna
vaccin
yopbdtm
yopddtm
tpayopo
tpapla
panel
b
c
e
respect
bar
show
averag
antibodi
titer
reciproc
sera
dilut
three
duplic
assay
use
pool
mous
sera
group
indic
micegroup
panel
b
c
mice
per
group
panel
e
standard
error
bar
shown
applic
vivo
protect
mice
immun
differ
dna
vaccin
indic
balbc
mice
challeng
lethal
dose
cfu
pesti
kim
strain
intranas
inocul
one
week
th
dna
immun
cumul
surviv
curv
plot
show
protect
group
micegroup
panel
ac
micegroup
panel
df
vector
group
includ
plot
neg
control
